Encouragingly for the medtech sector, many of the small and mid-sized medical device companies that have seen the most enthusiasm from shareholders can attribute their valuation rise to the successful development of new products. Little M&A activity has occurred here so far in 2018 – with one exception – meaning that innovation has in many cases been rewarded.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,